Your browser doesn't support javascript.
loading
Diagnosis and treatment progress of chronic myeloid leukemia / 白血病·淋巴瘤
Article in Zh | WPRIM | ID: wpr-799283
Responsible library: WPRO
ABSTRACT
Chronic myeloid leukemia (CML) has made a milestone progress due to the development of the first generation tyrosine kinase inhibitor(TKI). Nowadays, most clinical trials in CML focus on discontinuation, even the second discontinuation, and the third generation TKI against T315I mutation. The conventional treatments are more focused on decreasing BCR-ABL transcripts rapidly. At the same time, the treatment management of some special patients has been valued.
Key words
Full text: 1 Index: WPRIM Type of study: Diagnostic_studies Language: Zh Journal: Journal of Leukemia & Lymphoma Year: 2020 Type: Article
Full text: 1 Index: WPRIM Type of study: Diagnostic_studies Language: Zh Journal: Journal of Leukemia & Lymphoma Year: 2020 Type: Article